AEON Biopharma Inc. (AEON)

AEON Chart

News and Press Releases

We searched over 50 sources and couldn't find any news or press releases related to AEON Biopharma Inc..

Here are some articles we think you might like.

• Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease

  GlobeNewsWire | October 22nd

  REGN
• Dupixent® (dupilumab) is the First Biologic to Significantly Reduce Itch and Skin Lesions in Phase 3 Trial for Prurigo Nodularis, Demonstrating the Role of Type 2 Inflammation in this Disease

  PRNewsWire | October 22nd

  REGN
• 3 Reasons To Invest Like Buffett And Buy Bristol Myers

  Seeking Alpha | October 21st

  BMY
• Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q3 2021 Results - Earnings Call Transcript

  Seeking Alpha | October 21st

  PSTV
• Iveric Bio Announces Pricing of Upsized Public Offering of Common Stock

  Business Wire | October 21st

  ISEE
• Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors

  Business Wire | October 21st

  NVAX
• Ginkgo Bioworks Investor Alert

  Newsfile Corp | October 21st

  DNA
• Revance Therapeutics Update

  Newsfile Corp | October 21st

  RVNC
• Cassava Class Action Reminder

  Newsfile Corp | October 21st

  SAVA
• Organogenesis Update

  Newsfile Corp | October 21st

  ORGO
• Eargo Shareholder Alert

  Newsfile Corp | October 21st

  EAR
• NVAX Alert: Berman Tabacco Announces Investigation of Novavax, Inc. for Potential Securities Law Violations

  Newsfile Corp | October 21st

  NVAX
• Ex-Athira Pharma CEO Leen Kawas resigns and leaves board after image manipulation investigation

  GeekWire | October 21st

  ATHA
• Premier, Inc. Declares Quarterly Cash Dividend

  Business Wire | October 21st

  PINC
• CDC panel unanimously endorses Moderna and J&J Covid boosters, sending to director for final approval

  CNBC | October 21st

  JNJMRNA

Company Info